21.57 0.00 (0.00%)
After hours: 4:54PM EDT
|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||21.53 - 22.07|
|52 Week Range||9.91 - 24.07|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 7, 2018 - May 11, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||25.75|
Investors are always looking for growth in small-cap stocks like Aramus SA. (WSE:ARA), with a market cap of ZŁ6.51M. However, an important fact which most ignore is: how financially healthyRead More...
American Renal Associates Holdings (ARA) operates its dialysis clinics mainly through a joint venture model. Most of its clinics are maintained as separate joint ventures in which American Renal Holdings has the controlling interest, and its nephrologist partners and other joint venture partners have a noncontrolling interest.
Its nephrologist partners also generate awareness and recognition about American Renal Associates Holdings within the broader nephrology community and provide recommendations of potential new nephrologist partners. The company intends to leverage its joint venture model to continue to develop de novo clinics in new as well as existing markets in the United States. At the end of December 2017, American Renal Associates Holdings had 177 clinics developed as de novo clinics in its portfolio.
American Renal Associates Holdings (ARA) is the largest dialysis services provider in the United States with an exclusive focus on joint venture partnerships with physicians. Of the three analysts covering American Renal Associate Holdings in March 2018, two analysts have given the stock a “strong buy” rating and one analyst has given it a “buy” rating. Of the four analysts covering Civitas Solutions (CIVI) in March 2018, two analysts have given the stock a “strong buy” rating, and two analysts have given it a “buy” rating.
NEW YORK, NY / ACCESSWIRE / March 7, 2018 / American Renal Associates Holdings, Inc. (NYSE: ARA ) will be discussing their earnings results in their Q4 Earnings Call to be held on March 7, 2018, at 9:00 ...
On a per-share basis, the Beverly, Massachusetts-based company said it had net income of 5 cents. Earnings, adjusted for non-recurring costs, came to 18 cents per share. The results topped Wall Street ...
American Renal Associates Holdings, Inc. , a leading provider of outpatient dialysis services, today announced financial and operating results for the quarter and year ended December 31, 2017.
While small-cap stocks, such as American Renal Associates Holdings Inc (NYSE:ARA) with its market cap of US$661.30M, are popular for their explosive growth, investors should also be aware of theirRead More...
American Renal Associates Holdings, Inc. , a leading provider of outpatient dialysis services, today announced that the Company continues to build on its exceptional track record of sustained outperformance in the areas of patient quality and patient satisfaction, as well as physician satisfaction, based on recently released results issued by the Centers for Medicare & Medicaid Services end-stage renal ...
American Renal Associates Holdings, Inc. , a leading provider of dialysis services, announced today that it will release its fourth quarter 2017 financial results after the market close on Tuesday, March 6, 2018, to be followed by a conference call on Wednesday, March 7, 2018 at 9:00 a.m.
NEW YORK, Feb. 12, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of A. ...
American Renal Associates Holdings, Inc. , a leading provider of outpatient dialysis services, today announced that the Company has entered into a Stipulation of Settlement with the lead plaintiff in the shareholder class action lawsuit pending against it in the United States District Court for the District of Massachusetts, Esposito, et al.
Shareholder rights law firm Robbins Arroyo LLP is investigating whether certain officers and directors of American Renal Associates, Inc. breached their fiduciary duties to shareholders.
On a per-share basis, the Beverly, Massachusetts-based company said it had profit of 24 cents. Earnings, adjusted for non-recurring gains, came to 19 cents per share. The results surpassed Wall Street ...
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to American Renal Associates Holdings, Inc. Here are 5 ETFs with the largest exposure to ARA-US. Comparing the performance and risk of American Renal Associates Holdings, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns ... Read more (Read more...)
American Renal Associates Holdings, Inc. , a leading provider of outpatient dialysis services, today announced financial and operating results for the third quarter ended September 30, 2017.
With an ROE of 32.20%, American Renal Associates Holdings Inc (NYSE:ARA) outpaced its own industry which delivered a less exciting 14.78% over the past year. On the surface, this looksRead More...